CANF Archives - Page 4 of 4 - Blue Horseshoe Stocks

Blue Horseshoe Stocks: PVSP, MJMD Recaps & More

Pervasip Corp. PVSP

Our first order of business in yesterday’s premarket report was to call attention back to PVSP, and the timing turned out to be excellent.

The stock touched a daily low of .0018 just after 10AM, and spent most of the rest of the session bulling its way to new highs. Shortly after 2PM, it hit .0028. That registers as a 55% intraday gain.

PVSP was trading at an absolute bottom (.0001) as recently as February 28th, meaning that yesterday’s high represented a ridiculously strong upswing of 2700% in under a month!

We’ll continue to keep PVSP in mind as we await further updates on last week’s acquisition of a Colorado-based hydroponics distributor. >> READ PR

MediJane Holdings, Inc. MJMD

MJMD appeared in our extended watchlist yesterday, and turned out to be another impeccably-timed alert. The momentum we observed in the stock during a routine scan on Friday made its inclusion on our radar a no-brainer.

MJMD exploded out of the gate at .005 and ran hard, reaching its peak at .02, and marking an exceptional intraday run of 300% It did so on nearly ten times its 30-day average volume, so big cheers go out to any of our readers who were able to hitch a ride on that freight train!

It’s good to see some liquidity flowing back into cannabis stocks, which endured a noticeable slump in recent months. Another one that caught our eye with a big move yesterday was LGBI, and we’ll be on the lookout for any dip-and-rip chances it may provide.

Kraft Foods Group, Inc. KRFT – Options

As our regular reader are surely aware, we’ve been tracking KRFT Calls ever since the big news of the Heinz merger came across the wires last week. Our initial ideas were to monitor April 17th, $75, $80, and $85 Calls and it worked out in spades as the stock approached the $90-mark on Friday.

Yesterday continued the upward momentum, leading KRFT to break $90, and that left a couple of our observed contracts in a good position to continue their gains. While the $70’s were pushed a little deep into the money to make any further appreciable moves, the $75’s and $80’s still managed to provide opportunities for daytrades.

04/17 $80 Calls – Range: 7.90-10.30 – Max Gain: 30%
04/17 $85 Calls – Range:3.40-5.61 – Max Gain: 65%

Those traders savvy enough to roll their strike price up to the $90-level would have been duly rewarded as the 04/17 $90 Calls made their way from .91-1.91, for a 110% intraday move. Should KRFT continue its upward momentum, those will most likely be an area of interest for us in coming sessions.

Extended Watchlist:
AXPW, DANG, HKTV, BGMD, BCRX, CANF, CHTR, PCLN

Blue Horseshoe Stocks: Options Recap, Cyber-Security Watchlist & More

Recapping Friday’s Options Ideas

Nike, Inc. NKE – On Friday morning, NKE was in the midst of gapping up on the heels of its earnings call, and we came up with daytrading ideas for the $100-104 Weekly Calls. There turned out to be great opportunity in that range as NKE surged to a daily high of 103.79:

$100 Calls – Range:1.38-3.75 – Max Gain: 172%
$101 Calls – Range: .70-2.80 – Max Gain: 300%
$102 Calls – Range: .18-1.75 – Max Gain: 872%
$103 Calls – Range: .10-.85 – Max Gain: 750%

____

Prothena Corp plc PRTA was the other options target we were monitoring on Friday for swing trades. Specifically, we were looking at the $40 and $45 Calls, and both sets of contracts made big initial moves, followed by pullbacks and additional swings later in the session.

The $35 Calls first shot out of the gate trading at a low of 5.32 and running as high as 9.50 for an initial pop of 78%, before tapering back to 2.40 then recovering to 3.92, for an added 63% move.

The $40’s would open with a 116% spike from 3.00-6.50, followed by a later swing from 2.45-2.90, an extra 18% swing.

Cyber-Security Watchlist

We want to re-radar a couple of cyber security firms that we’ve mentioned in the past, as they have both been on a bit of a downtrend, yet appear to be gapping up this morning.

CyberArk Software Ltd. CYBR & FireEye, Inc. FEYE are going to go back on our active watchlist as we kick off a new trading week. Once we’re able to confirm reversals for each of these plays, we can then begin to formulate options strategies accordingly. Stay tuned to our reports this week, and we’ll be sure to have some ideas to pass along.

Extended Watchlist:
IMGN, FRSH, MCP, CAPN, PAL, CANF, AMBS(On Bottom-Watch)

Blue Horseshoe Stocks: TRXC Recap & Much More

TransEnterix Inc. TRXC

TRXC stood out among the other mentions in Friday’s premarket report. Following our tag of this stock it shot quite rapidly from an early low of 2.73, and reached a subsequent high of 4.05 shortly after 11AM EST.

We want to congratulate any of our reader who were able to take advantage of that timely alert which yielded the opportunity at intraday gains of up to 48% The healthy spike came on nearly tenfold the 3-month average trading volume.

Friday’s move came in conjunction with the announcement of successful pre-clinical trials for its SurgiBot minimally invasive surgery system. Two different doctors used TRXC’s product in actual medical procedures and subsequently offered their endorsements. It is an important step on the way to FDA application submission, which the company has stated should be on the table by mid-2015. Thus, TRXC may be one that we’ll want to have on a more long-term watch.

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today announced the successful completion of four general surgery and urology procedures using its SurgiBot system patient-side robotic surgery system. >> FULL PR

The First Marblehead Corp. FMD

We also wanted to give a quick nod to FMD for a solid performance following its inclusion in Friday morning’s watchlist. The stock found a low of 4.65 within the first several minutes of the open, and would go on to end the day with a on a high note, reaching as high as 5.35 and marking a respectable intraday move of 15%

Nuvilex, Inc. NVLX

Our first mention of NVLX dates all way back to August of 2013 when we released a special report on the company and its pancreatic cancer treatment, which at the time was in the early stages of Phase-2 trials. (Read the Special Report HERE)

A major development hit the presswires this morning regarding the FDA’s granting of ‘Orphan Drug’ status to that treatment, so we wanted to bring the stock back into the mix.

It’s coming off of a recent bottom as well, so NVLX is certainly going to be reserved a spot on our watchlist as the story continues to play out. The company has stated that Phase-3 trials should begin in 2015.

SILVER SPRING, Md., Dec. 22, 2014 (GLOBE NEWSWIRE) — Nuvilex, Inc. (NVLX), a clinical-stage biotechnology company providing cell therapy solutions for the treatment of diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Nuvilex orphan drug designation for its pancreatic cancer treatment. >> FULL PR

Rite-Aid Corp. RAD

We tagged RAD for tracking this past Tuesday, and the stock responded with a respectable performance on the week. An earnings beat as well as heightened guidance facilitated a healthy move from a low of 5.73 to a subsequent high of 7.05, marking a 23% intraweek spike.

Extended Watchlist:
GSS(Bottom Bouncer coming off 52-week lows), CANF, APP, TGE, ACHN

CETV, PROW, TGRO, TSEM, ORMP, ARIA & Extended Watchlist

Central European Media Enterprises, Inc. CETV

We’ve been tracking CETV for quite some time now, having initially alerted the stock on May 10th following a routine Form-4 (Insider Trading) scan. We learned that a large block ($75M worth) of shares had just been purchased by none other than Time Warner, and took notice immediately. We observed the stock make a monster move of 147% before being subjected to a large gap-down (hit 52-week low @ 2.03) at the end of October.

We decided to re-alert the stock on November 13th, by which time it was trading as low as 2.12. Since then, it has been stair-stepping its way back up, having seen highs in the high 3.20’s last week. We’re looking for a breach of the 50 and 200DMA’s (3.48, 3.86 respectively), following which the filling of that large gap on the chart could result in further significant increases.

Progress Watch Corp. PROW

On Friday, we mentioned that we were looking for a break of a key resistance areat on PROW, the 200DMA residing in the .007’s, and the stock indeed surpassed and held above that mark into the close. After opening at .0065, PROW would see a subsequent high of .0098, an intraday run of 51% on more than 5x its 3mo. average volume.

We warned of PROW’s extremely tight share structure, which allows for significant increases on relatively small amounts of buying pressure. The stock demonstrated our point quite succinctly.

Tiger Oil & Energy, Inc. TGRO

Also appearing in Friday’s report was another of our recent favorites in TGRO, a stock which has afforded us ample opportunities in the two weeks that we’ve been tracking it. With our first alert coming exactly two weeks ago, the stock has run from a low .36, all the way up to 1.08, good for a mega-gain of 200%

For those who may have only caught Friday’s alert, there was still the chance to make up to 43% in profit from TGRO’s daily low of .755 to the 1.08 high.

Extended Watchlist Winners

Friday’s Extended Watchlist also included a few choice picks that put up very respectable sessions to close out the week.

Tower Semiconductor Ltd. TSEM enjoyed a nice move of 26% trading in its daily range from 6.00 to 7.53.

Oramed Pharmaceuticals, Inc. ORMP spiked 36% running from 10.05 to 13.69.

ARIAD Pharmaceuticals, Inc. ARIA has been an Extended Watchlist mainstay since Nov. 12th, being as low as 2.31. Friday’s high of 7.75 represents a great run of 236% in just a little over five weeks.

Extended Watchlist:
BISU, AMRN, XRTX, CANF, CBMX, WPCS, S, AAPL(Big news with China Mobile),